Defilade Capital Management »

Mereo Biopharma Group Plc ads shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Mereo Biopharma Group Plc ads (MREO) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Mereo Biopharma Group Plc ads

Tip: Access up to 7 years of quarterly data

All positions including Mereo Biopharma Group Plc ads held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mereo Biopharma Group Plc ads by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 7.6M 0.33

More positions owned by Defilade Capital Management

Zimmer Holdings (ZBH)
Henry Schein (HSIC)
Becton, Dickinson and (BDX)
Pfizer (PFE)
Dex (DXCM)
ICU Medical, Incorporated (ICUI)
Insmed Com Par $.01 (INSM)
Intuitive Surgical Com New (ISRG)
Revolution Medicines (RVMD)
Globus Med Cl A (GMED)
Neurocrine Biosciences (NBIX)
Denali Therapeutics (DNLI)
Ptc Therapeutics I (PTCT)
Olema Pharmaceuticals (OLMA)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Mereo Biopharma Group Plc ads

Rubric Capital Management
EcoR1 Capital
683 Capital Management
Bank of America Corporation
Defilade Capital Management
Newtyn Management
Millennium Management
Tejara Capital
Diadema Partners
UBS Group
Sontag Advisory
Susquehanna International
Citadel Advisors
Simplex Trading
EntryPoint Capital

View all funds holding Mereo Biopharma Group Plc ads